What are the precautions with proton pump inhibitor use for reflux disease?

被引:2
|
作者
Mospan, Cortney M. [1 ,2 ]
机构
[1] E Tennessee State Univ, Bill Gatton Coll Pharm, Pharm Practice, Johnson City, TN 37614 USA
[2] Univ Charitable Pharm, Columbus, OH USA
关键词
gastroesophageal reflux disease; proton pump inhibitor; comorbidities; older adults; clopidogrel; fractures; THERAPY; SAFETY;
D O I
10.1097/01.JAA.0000473372.47749.16
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gastroesophageal reflux disease (GERD) affects 10% to 20% of the western world's population. Current treatment guidelines recommend proton pump inhibitors (PPIs) as first-line therapy. Although PPIs cause mild adverse reactions, they pose risks, particularly for older adults with comorbidities.
引用
收藏
页码:23 / 26
页数:3
相关论文
共 50 条
  • [21] The rising trend of on-demand and intermittent proton pump inhibitor therapy in gastroesophageal reflux disease: What is the evidence?
    Bautista, Jimmy M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : S112 - S114
  • [22] Persistent Reflux Symptoms in the Proton Pump Inhibitor Era: The Changing Face of Gastroesophageal Reflux Disease
    Dellon, Evan S.
    Shaheen, Nicholas J.
    GASTROENTEROLOGY, 2010, 139 (01) : 7 - U30
  • [23] Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease
    Tariq, Muhammad Ali
    Ahmed, Bilal
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2022, 28 (01) : 164 - 164
  • [24] Gastro-Oesophageal Reflux Disease Beyond Proton Pump Inhibitor Therapy
    Hershcovici, Tiberiu
    Fass, Ronnie
    DRUGS, 2011, 71 (18) : 2381 - 2389
  • [25] Treatment of proton pump inhibitor-resistant patients with gastroesophageal reflux disease
    Yoshikazu Kinoshita
    Hideaki Kazumori
    Shunji Ishihara
    Journal of Gastroenterology, 2006, 41 : 286 - 287
  • [26] A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease
    Hillman, L.
    Yadlapati, R.
    Thuluvath, A. J.
    Berendsen, M. A.
    Pandolfino, J. E.
    DISEASES OF THE ESOPHAGUS, 2017, 30 (09): : 1 - 15
  • [27] Treatment of proton pump inhibitor-resistant patients with gastroesophageal reflux disease
    Kinoshita, Y
    Kazumori, H
    Ishihara, S
    JOURNAL OF GASTROENTEROLOGY, 2006, 41 (03) : 286 - 287
  • [28] Review of antireflux procedures for proton pump inhibitor nonresponsive gastroesophageal reflux disease
    Hillman, L.
    Yadlapati, R.
    Whitsett, M.
    Thuluvath, A. J.
    Berendsen, M. A.
    Pandolfino, J. E.
    DISEASES OF THE ESOPHAGUS, 2017, 30 (09) : 1 - 14
  • [29] Therapeutic choices in reflux disease: Defining the criteria for selecting a proton pump inhibitor
    Freston, JW
    AMERICAN JOURNAL OF MEDICINE, 2004, 117 : 14S - 22S
  • [30] Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions
    Mermelstein, Joseph
    Mermelstein, Alanna Chait
    Chait, Maxwell M.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2018, 11 : 119 - 134